Viewing Study NCT02175758


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-05 @ 5:27 PM
Study NCT ID: NCT02175758
Status: COMPLETED
Last Update Posted: 2019-04-30
First Post: 2014-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection
Sponsor: Gilead Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-07-07
Start Date Type: ACTUAL
Primary Completion Date: 2018-06-21
Primary Completion Date Type: ACTUAL
Completion Date: 2018-09-13
Completion Date Type: ACTUAL
First Submit Date: 2014-06-24
First Submit QC Date: None
Study First Post Date: 2014-06-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-02-28
Results First Submit QC Date: None
Results First Post Date: 2019-04-30
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-04-05
Last Update Post Date: 2019-04-30
Last Update Post Date Type: ACTUAL